IFNG and non-small cell lung carcinoma: Evidence shows that PD-L1 mRNA and protein expression on CAFs derived from NSCLC is upregulated by exogenous supplementation with interferon-gamma (IFN-γ) which has shown to increase exosomal PD-L1 release in tumor cells [90].